Mckinley Capital Management LLC Uro Gen Pharma Ltd. Transaction History

Mckinley Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$32.75 - $40.35 $39,234 - $48,339	-1,198 Closed	0 $0
Q1 2019 May 02, 2019	SELL	$35.47 - $54.55 $614,375 - $944,860	-17,321 Reduced 93.53%	1,198 $44,000
Q4 2018 Feb 11, 2019	BUY	$38.35 - $50.39 $14,803 - $19,450	386 Added 2.13%	18,519 $798,000
Q3 2018 Nov 08, 2018	SELL	$41.65 - $51.7 $45,398 - $56,353	-1,090 Reduced 5.67%	18,133 $856,000
Q2 2018 Jul 13, 2018	BUY	$48.35 - $65.33 $880,453 - $1.19 Million	18,210 Added 1797.63%	19,223 $957,000
Q1 2018 May 04, 2018	BUY	$38.64 - $57.54 $39,142 - $58,288	1,013 New	1,013 $50,000

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $242M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

Stay updated on Mckinley Capital Management LLC with notifications on news.